Evidence map›Paper›PMID 42269013›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

BACH1 orchestrates macrophage state transitions to coordinate regenerative inflammation.

Noemí Caballero-Sánchez, Petros Tzerpos, Krisztian Bene, Laszlo Halasz, Dóra Bojcsuk, Gergely Nagy, Maysaa A Ali, Timea Cseh, Szilard Poliska, Matthew J Borok and 6 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Noemí Caballero-SánchezDoctoral School of Molecular Cell and Immunobiology, Faculty of Medicine, University of Debrecen, Hungary.
Petros TzerposDepartment of Biochemistry and Molecular Biology, Nuclear Receptor Research Laboratory, Faculty of Medicine, University of Debrecen, Hungary.
Krisztian BeneDepartment of Biochemistry and Molecular Biology, Nuclear Receptor Research Laboratory, Faculty of Medicine, University of Debrecen, Hungary.
Laszlo HalaszDepartments of Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Dóra BojcsukDepartment of Biochemistry and Molecular Biology, Nuclear Receptor Research Laboratory, Faculty of Medicine, University of Debrecen, Hungary.
Gergely NagyDepartment of Biochemistry and Molecular Biology, Nuclear Receptor Research Laboratory, Faculty of Medicine, University of Debrecen, Hungary.
Maysaa A AliDoctoral School of Molecular Cell and Immunobiology, Faculty of Medicine, University of Debrecen, Hungary.
Timea CsehDepartment of Biochemistry and Molecular Biology, Nuclear Receptor Research Laboratory, Faculty of Medicine, University of Debrecen, Hungary.
Szilard PoliskaGenomic Medicine and Bioinformatics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Matthew J BorokINSERM U955 IMRB, University Paris-Est Créteil, Créteil, France.
Jordan SchererDepartments of Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.ORCID 0009-0005-2298-9504
Frederic RelaixINSERM U955 IMRB, University Paris-Est Créteil, Créteil, France.
Enrique SaezDepartment of Molecular and Cellular Biology, Scripps Research, La Jolla, CA, United States.
Zsolt CzimmererInstitute of Genetics, HUN-REN Biological Research Centre, Szeged, Hungary.
Andreas PatsalosDepartments of Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Laszlo NagyDepartment of Biochemistry and Molecular Biology, Nuclear Receptor Research Laboratory, Faculty of Medicine, University of Debrecen, Hungary.

Funding

Intracellular trafficking of the essential signaling metabolite heme in myeloid cells: impact on physiology and diseaseR01DK138430 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI Laszlo Nagy, Enrique Saez · 2024 to 2026
$3.0M
Nuclear receptor, PPARg in macrophage polarization, hyperinflammatory gene expression and lung injuryR01HL170426 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Laszlo Nagy · 2024 to 2026
$1.9M
BACH1 as a novel pioneer repressor in macrophages: impact on homeostasis and inflammationR01AI185363 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Laszlo Nagy · 2024 to 2026
$1.7M
European Union's Horizon 2020 research and innovation 860034Hungarian Scientific Research Fund K147147Hungarian Scientific Research Fund KKP129909Hungarian Scientific Research Fund OTKA FK146945Hungarian Scientific Research Fund OTKA PD137902Initial Training Network NR-NET 606806Marie Curie Intra-European Fellowship for Experienced Researchers EU FP7/2007-2013NHLBI NIH HHS R01 HL170426NIAID NIH HHS R01 AI185363NIDDK NIH HHS R01 DK138430NIH HHS AI185363NIH HHS DK138430NIH HHS HL170426
6 · The paper itself

Abstract

Efficient tissue regeneration requires the precise coordination of inflammatory and regenerative programs, principally mediated by monocyte-derived macrophages. However, the transcriptional wiring and epigenomic processes behind complex macrophage subtype specification and transition between the different states are not known. Here we have identified the transcriptional repressor BACH1 as a critical, cell-intrinsic regulator of monocyte-derived macrophage specification during skeletal muscle regeneration. Using a myeloid-specific BACH1 knockout mouse model, we demonstrate that BACH1 deficiency disrupts the temporal coordination of monocyte-to-macrophage differentiation, leading to aberrant macrophage subsets with concurrent opposing pro- and anti-inflammatory features. Single-cell RNA-sequencing profiling reveals that BACH1 controls a core transcriptional network, including Nfkb1, Cebpb, and interferon signaling, governing inflammatory resolution and functional macrophage specialization. Mechanistically, BACH1 loss accelerates macrophage differentiation but also affects its core cellular identity, resulting in sustained, rather than declining inflammatory programs including upregulation of Il1b and thus, defective tissue remodeling. These immune alterations compromise the paracrine landscape during regenerative inflammation and impair muscle stem cell differentiation. Our findings establish BACH1 as a molecular tuner or controller that integrates early innate immune signaling with regenerative output, positioning it as a central node linking transcriptional control, immune fate decisions, and tissue repair.

Indexed as

Basic-Leucine Zipper Transcription FactorsInflammationMacrophagesMuscle, SkeletalRegenerationAnimalsCell DifferentiationMiceMice, KnockoutBach1 protein, mouseBasic-Leucine Zipper Transcription FactorsBACH1inflammationmuscle repairregenerative inflammationtranscription factor

Identifiers

PMID42269013
PMCPMC13253109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.